CVE-2022-26235

{"cve": {"data_type": "CVE", "references": {"reference_data": [{"url": "https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance", "name": "https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance", "tags": ["Product", "Vendor Advisory"], "refsource": "MISC"}, {"url": "https://pastebin.com/amgw9pE7", "name": "https://pastebin.com/amgw9pE7", "tags": ["Third Party Advisory"], "refsource": "MISC"}]}, "data_format": "MITRE", "description": {"description_data": [{"lang": "en", "value": "A vulnerability was discovered in the Remisol Advance v2.0.12.1 and below for the Normand Message Server. On installation, the permissions set by Remisol Advance allow non-privileged users to overwrite and/or manipulate executables and libraries that run as the elevated SYSTEM user on Windows."}]}, "problemtype": {"problemtype_data": [{"description": [{"lang": "en", "value": "CWE-276"}]}]}, "data_version": "4.0", "CVE_data_meta": {"ID": "CVE-2022-26235", "ASSIGNER": "cve@mitre.org"}}, "impact": {"baseMetricV3": {"cvssV3": {"scope": "UNCHANGED", "version": "3.1", "baseScore": 7.8, "attackVector": "LOCAL", "baseSeverity": "HIGH", "vectorString": "CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H", "integrityImpact": "HIGH", "userInteraction": "NONE", "attackComplexity": "LOW", "availabilityImpact": "HIGH", "privilegesRequired": "LOW", "confidentialityImpact": "HIGH"}, "impactScore": 5.9, "exploitabilityScore": 1.8}}, "publishedDate": "2022-10-06T18:15Z", "configurations": {"nodes": [{"children": [], "operator": "OR", "cpe_match": [{"cpe23Uri": "cpe:2.3:a:beckmancoulter:remisol_advance:*:*:*:*:*:*:*:*", "cpe_name": [], "vulnerable": true, "versionEndIncluding": "2.0.12.1"}]}], "CVE_data_version": "4.0"}, "lastModifiedDate": "2022-10-11T15:07Z"}